SS
XBIO icon

SBI Securities’s Xenetic Biosciences XBIO Stock Holding History

SBI Securities’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.91K Buy
+1,000
New +$3.09K ﹤0.01% 2414
2025
Q4 		– Sell
-5
Closed -$16 – 4250
2025
Q3 		$16 Hold
5
– – ﹤0.01% 3957
2025
Q2 		$20 Hold
5
– – ﹤0.01% 3919
2025
Q1 		$13 Hold
5
– – ﹤0.01% 3930
2024
Q4 		$20 Buy
+5
New +$20 ﹤0.01% 3833

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DWM
Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

SBI Securities's XBIO Position: Q2 2026 in Review

SBI Securities opened a new position in Xenetic Biosciences (XBIO) in Q2 2026: 1,000 shares worth $2.91K. The stake represents ﹤0.01% of the portfolio and ranks #2414 among its holdings. This is a return to the name: SBI Securities previously reported a position in XBIO as recently as Q3 2025.

SBI Securities first reported a position in XBIO in Q4 2024 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold XBIO as of Q2 2026.

  • SBI Securities held 1,000 shares of Xenetic Biosciences worth $2.91K as of Q2 2026.
  • Xenetic Biosciences was a new SBI Securities position in Q2 2026.
  • Xenetic Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2414 holding.
  • SBI Securities first reported a position in Xenetic Biosciences in Q4 2024 and has held it in 5 quarters since.
  • 8 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.